Sofia Chierchio is a staff writer at Forbes covering wealth management. Previously at Forbes, she reported on a variety of topics such as the business of sports and artificial intelligence. Sofia ...

QuidelOrtho (QDEL) is looking to sell its point-of-care testing unit at a $1.5B valuation, and private equity groups have already expressed interest in the transaction, The Financial Times reported on ...

Looking ahead to 2030, our model projects QDEL could trade at an average price of $28.11, with a potential range between $21.08 and $35.13. This represents a potential 61.2% return from today's price.

Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...

The uACR test is a simple urine test that can detect kidney disease risk early, even before symptoms appear. High blood pressure and diabetes are the two main causes of kidney failure in the U.S. High ...